The major inflammatory cytokines interleukin(IL)1b, IL6 and tumor necrosis factor a (TNFa) play a crucial role in infection, inflammation and stress responses. Previously, three coding genes were resequenced, identifying promoter polymorphisms that were used in association studies of neurodegenerative diseases, metabolic disorders and cancer. These studies have produced intriguing but inconsistent results, potentially because the known functional variants: IL1B-511 C4T, IL6-174 G4C and TNF-308 G4A provided an incomplete picture of the total functional diversity at these genes. Therefore, we created marker panels for IL1B, IL6 and TNF/LTA that included the known functional marker but also other markers evenly spaced and with sufficient density to identify haplotype block structure and to maximize haplotype diversity. A total of 26 markers were genotyped in 96 US Caucasians and 96 African Americans. In both populations, a single block with little evidence of historical recombination was observed in IL1B, IL6 and TNF/LTA. For each gene, haplotypes captured the information content of each functional locus, even if that locus was not genotyped, and presumably haplotypes would capture the signal from unknown functional loci whose alleles are of moderate abundance. This study demonstrates the utility of using gene haplotype maps and marker panels as tools for linkage studies on related phenotypes.
Introduction
Interleukin (IL) 1b, IL6 and tumor necrosis factor a (TNFa) are the major inflammatory cytokines that regulate peripheral and CNS-mediated responses to infection and inflammation. 1 These cytokines are products of both activated microglia and activated astrocytes that powerfully stimulate their activity. 2 They have many common redundant and pleiotropic effects, such as T-and B-cell activation, that together contribute to the inflammatory process. Many systemic acute-phase effects are due to the combined action of IL1b, IL6 and TNFa. They play a crucial role in the activation of the hypothalamo-pituitary-adrenal (HPA) axis response to various threats to homeostasis. 3 In addition, they are implicated in the pathophysiology of several diseases, a selection of which includes neurodegenerative disorders, 4 cardiovascular disease, 5 depression, 6 addictions 7 and pain. 8 Since these and other immune-related disorders are heritable, [9] [10] [11] [12] [13] it can be speculated that part of their genetic background is explained by genetic variation in inflammatory genes producing changes in the amount or structure of these genes. Therefore, genes encoding IL1b, IL6 and TNFa were screened for common functional polymorphisms for association and linkage studies.
Chromosome 2q14-21 contains a cluster of IL1-related genes, including IL1A, IL1B and IL1 receptor antagonist protein (IL1RN). Here, we have focused on IL1B, because of its interaction with IL6 and TNF in central and peripheral immune response. IL1B has seven exons and is 7 kb in length. In 1992, Pociot et al 14 identified a biallelic (C/T) polymorphism in the IL1B-promoter region (position À511) that affects IL1b secretion in vitro.
14 This marker was used in association studies of the susceptibility to chronic hepatitis B, 15 gastric cancer, 16 multiple sclerosis, 17 Alzheimer's disease 18 and sporadic Parkinson's disease, 19 but association results have been inconsistent across different studies.
IL6 is mapped to chromosome 7p21-24 with an upstream promoter containing 303 bp. It has five exons spanning 4.8 kb in length. A common G/C polymorphism of the IL6 promoter on position À174 has been shown to influence in vivo protein expression. 20 It has been investigated in a wide variety of diseases, including multiple myeloma, 21 coronary heart disease, 22 endometriosis 23 and ovarian cancer. 24 However, the linkage studies are contradictory. 25 In addition, this functional marker may be rare in certain populations 26 that makes it useless in limited size datasets.
LTA and TNF are located next to each other on chromosome 6p21.3 having three and four exons and spanning 2 and 2.7 kb, respectively. A dimorphism with potential functional relevance (G to A transition at position À308 in the promoter/enhancer region) has been described for the TNF locus. 27 The minor À308A allele was shown to be strongly associated with human leukocyte antigen (HLA)-DR3, known to be related to a TNFa 'high producer' phenotype. 28 In support for a clinical relevance, the À308A allele is associated with a seven-fold increased risk for cerebral complications of malaria 29 and with a worse prognosis and longer disease duration in dermatitis herpetiformis. 30 However, the same marker was not responsible for differential TNFa production induced by standard in vitro stimuli. 31 Although taking into consideration the importance and informativeness of known functional loci in inflammatory genes, it can be assumed that consistent pictures of IL1b, IL6 and TNF genotype-phenotype relationships are yet to emerge. Other functional loci may be present, including polymorphisms which are known but which have not yet been recognized to be functional. A haplotype approach combining known functional polymorphisms with a series of loci chosen for haplotype informativeness could comprehensively capture the potential information content on immune gene functional variants of moderate abundance. 32 In this study, we report a haplotype map for IL1B, IL6 and TNF/LTA for two populations, American Caucasians and African Americans, by genotyping a panel of SNP markers and the known functional polymorphisms in these populations. For each gene, we also describe marker panels that maximize haplotype information content.
Results and discussion
Of a total of 26 markers in three immune genes, 25 were polymorphic both in US Caucasians and African Americans. IL6 marker #8 (rs2069860) was monomorphic in Caucasians. Dramatic interpopulation differences in allele frequencies were observed for many of the markers. Allele frequencies of all markers and their locations in the genes are shown in Table 1a -c. For IL1B, a functional promoter polymorphism (marker #6) is Haplotype structure of IL1B, IL6 and TNF/LTA I Belfer et al located in 5 0 UTR, one synonymous substitution is in exon 5, one marker is located in the gene 3 0 UTR region, and the rest of the markers are in the intronic space or intergenic region upstream and downstream of IL1B ( Figure 1a ). For IL6, a known promoter polymorphism (marker #4) and two nonsynonymous polymorphisms are located in exons 2 and 5, and the rest of the markers are in the intronic space and intergenic region upstream and downstream of IL6 (Figure 1b) . For TNF, one functional promoter polymorphism (marker #6) is located in the 5 0 UTR region (exon 1), two LTA markers are located in the gene 5 0 UTR region, one LTA nonsynonymous substitution is in exon 2, and the rest of the markers are in the sequence between LTA and TNF, and in intergenic region upstream of LTA and downstream of TNF (Figure 1c) .
Within the IL1B, IL6 and TNF/LTA regions, a single conserved haplotype block spanned each gene in both populations (Figure 2a-c) . For IL1B, the block size was 17 kb in the two populations, with some disruption of linkage disequilibrium (LD) in African Americans (Figure 2a ). For IL6, the block size was 13 kb in both populations, with little disruption of LD between certain loci (Figure 2b ). For TNF/LTA, the haplotype block size was 7 kb in both populations, with little disruption of LD in African Americans (Figure 2c ).
We have not directly measured admixture in either the Caucasian or African American populations studied here, yet both populations can be predicted to be admixed, the African American population more so. The potential effects of this admixture are several. Admixture would dilute differences between the populations and might be expected to increase haplotype diversity. It is therefore interesting to compare these results to those of Ackerman et al (2003) who investigated TNF haplotype structure in two African populations, Gambia and Malawi. 33 Using a 12-locus TNF haplotype, there were significant differences in haplotype frequency between the two African populations; however, the number of common haplotypes (five) was the same as observed here. The three overlapping SNP markers between our study and their study were TNF À1031 T/ C (rs1799964), TNF À857 C/T (rs1799724) and TNF À308 G/A (rs1800629). Evaluation of the Ackerman et al haplotypes reveals that the two most abundant haplotypes in the Malawian and Gambian Africans contain T, C and G alleles at these three SNPs. This corresponds exactly to the most abundant haplotypes we observed in both African Americans and Caucasians. These common haplotypes are thus relatively insensitive to Caucasian/ African admixture because of modest differences between Caucasians and Africans. Most sensitive for Haplotype frequencies for IL1B, IL6 and TNF/LTA in both populations are shown in Table 2a -c. For each population and haplotype block, 4-7 common (frequency Z0.05) haplotypes accounted for most of the total: 88-97% of Caucasian and 81-92% of African-American haplotypes. For US Caucasians and African Americans, the numbers of common (frequency Z0.05) haplotypes were: in IL1B, 4 and 7; in IL6, 4 and 6; in TNF/LTA, 6 and 5, respectively.
We evaluated haplotype diversity within each block by successively subtracting SNPs from the haplotypes to evaluate the increment/decrement in diversity contributed by each SNP. SNPs were serially subtracted in that order that minimized the decrement in diversity at each step, and until only a single SNP (ie the SNP with the highest heterozygosity) remained. The chosen measure of diversity (haplotype frequencies and diplotype heterozygosity) was recalculated for each size SNP panel (n, nÀ1y1). At some point for each haplotype block and for each population, adding or subtracting a SNP does not appreciably alter diversity, as shown in Figure 3 , panels a-c. For ILB and IL6, haplotype diversity was highest in African Americans. A similar number of markers (5-7) per each gene panel was necessary to capture maximum diversity in either population (with the exception of the IL1B haplotype block in African Americans, which required nine of 10 markers to capture maximum diversity). It is to be noted that this number represents an optimal panel, itself derived from the larger panel of SNP markers we genotyped.
For each immune gene, known functional promoter polymorphism was contained within the haplotype block. Within each block, haplotypes enabled high sensitivity of detection of the functional locus (when a functional allele was present, the particular haplotype(s) was present) and specificity of detection (when the haplotype(s) was present, the functional allele was present). For each of the three immune genes, the haplotype was capable of capturing all or almost all the information provided by directly genotyping the functional locus, in either population (Table 3 ). These SNP panels covering immune gene regions reliably capture haplotype diversity in different populations, even when not including known functional alleles. Certainly, genotyping of polymorphisms that affect gene expression and/or function is highly important in association/ linkage studies. However, there is a possibility that an unrecognized functional locus contributes to a phenotype. The focus of the haplotype-based approach to analyze case-control populations has been to detect the effects of every functional locus, known or unknown.
For IL1B, IL6 and TNF/LTA, we have created multilocus SNP panels to define haplotype structure across each gene region. Each panel is sufficient to capture the signal of the moderately abundant functional locus (or loci) at each gene, and these panels should also be informative for unknown functional alleles. One or more functional alleles could reside on a haplotype, emphasizing the importance of understanding haplotype structure in particular populations. These gene haplotype maps Haplotype structure of IL1B, IL6 and TNF/LTA I Belfer et al and marker panels provide a basis for future studies to investigate the role of genetic variation in physiology and pathophysiology related to immune genes' function.
Patients and methods

Participants
A total of 192 unrelated subjects were genotyped, including 96 individuals from each of two populations:
US Caucasians and African Americans. Informed consent was obtained according to human research protocols approved by the human research committees of the recruiting institutes, including the National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health and Rutgers University. All participants Haplotype structure of IL1B, IL6 and TNF/LTA I Belfer et al had been psychiatrically interviewed and none had been diagnosed with a psychiatric disorder.
SNP markers
The physical position and frequency of minor alleles from a commercial database (Celera Discovery System, CDS, February, 2004) were used to select SNPs (including known promoter substitutions in each gene). 5 0 nuclease assays (vide infra) were designed for 10 IL1B, nine IL6 and seven TNF/LTA SNPs and optimized, excluding SNPs with nearby secondary SNPs that might lead to selective nonamplification of alleles. These markers were nearly Genomic DNA Genomic DNA was extracted from lymphoblastoid cell lines, diluted to a concentration of 10 ng/ml. Aliquots (1 ml) were dried in 384-well plates.
Polymerase chain reaction (PCR) amplification
Genotyping was performed by the 5 0 nuclease method 34 using fluorogenic allele-specific probes. Oligonucleotide primer and probe sets were designed based on gene sequence from the CDS, February 2004. Primers and detection probes for each locus in each gene are listed in Table 4a -c. Reactions were in a 5 ml volume containing 2.375 ml TE, 2.5 ml Master Mix (ABI, Foster City, CA, USA) with AmpliTaq Gold s DNA Polymerase, dNTPs, Gold Buffer and MgCl 2 , 10 ng genomic DNA, 900 nM of each forward and reverse primer and 100 nM of each reporter and quencher probe. DNA was incubated at 501C for 2 min and at 951C for 10 min, and amplified on an ABI 9700 device for 40 cycles at 921C for 30 s and 601C for 75 s. Allele-specific signals were distinguished by measuring end point 6-FAM or VIC fluorescence intensities at 508 and 560 nm, respectively, and genotypes were generated using Sequence Detection V.1.7 (ABI).
Genotyping error rate was directly determined by regenotyping 25% of the samples, randomly chosen, for each locus. The overall error rate was o0.005. Genotype completion rate was 0.99. The potential for selective allele nonamplification due to secondary, unknown sequence polymorphisms appears to be low, on the basis that genotype completion rate was similar for all loci and all loci were in Hardy-Weinberg disequilibrium for both populations.
Haplotype analysis
Haplotype frequencies were estimated using a Bayesian approach implemented with PHASE. 35 These frequencies closely agreed with results from a maximum likelihood method implemented via an expectation-maximization (EM) algorithm. 36 Haploview version 2.0.2 (Whitehead Institute for Biomedical Research, USA) was used to produce LD matrices.
